for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

China Resources Pharmaceutical Group Ltd

3320.HK

Latest Trade

4.31HKD

Change

0.12(+2.86%)

Volume

6,374,000

Today's Range

4.17

 - 

4.32

52 Week Range

3.72

 - 

8.15

As of on the Hong Kong Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
4.19
Open
4.19
Volume
6,374,000
3M AVG Volume
123.72
Today's High
4.32
Today's Low
4.17
52 Week High
8.15
52 Week Low
3.72
Shares Out (MIL)
6,282.51
Market Cap (MIL)
26,323.72
Forward P/E
7.54
Dividend (Yield %)
2.63

Next Event

Full Year 2020 China Resources Pharmaceutical Group Ltd Earnings Release

Latest Developments

More

China Resources Pharmaceutical Says CR Pharmaceutical Proposes To Issue 2020 First Tranche Perpetual Corporate Bonds In PRC

China Resources Pharmaceutical Group Says Jiangzhong Pharmaceutical 9-Mth Net Profit RMB410.8 Million

China Resources Pharmaceutical Group Says Dong-E-E-Jiao Sees 9-Month Net Loss Attributable

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About China Resources Pharmaceutical Group Ltd

CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED is a Hongkong-based investment holding company. The Company, along with its subsidiaries, is principally engaged in the research and development, manufacturing, distribution and retail of pharmaceutical and other healthcare products. The Company mainly operates through three segments. Pharmaceutical Manufacturing segment is engaged in the research and development, manufacturing and sale of pharmaceutical and other healthcare products. Pharmaceutical Distribution segment is engaged in the provision of distribution solutions to pharmaceutical manufacturers and dispensers, such as hospitals and other medical institutions, distributors and retail pharmacies. Pharmaceutical Retail segment is involved in the operation of retail pharmacies in China and Hongkong.

Industry

Major Drugs

Contact Info

Room 4104-05, 41F,China Resources Buldng

No. 26, Harbour Road, Wan Chai

Hong Kong

+852.null.25938991

http://www.crpharm.com/

Executive Leadership

Chuncheng Wang

Non-Executive Chairman of the Board

Yuewei Han

Chief Executive Officer, Executive Director

Xiangming Li

Vice Chairman, Executive Director

Jingwen Weng

Chief Financial Officer, Vice President, Executive Director

Yi Feng

Chairman of CR Double-Crane

Key Stats

2.50 mean rating - 12 analysts
Sell
Hold
Buy
Revenue (MM, HKD)

2017

172.5K

2018

189.7K

2019

204.5K

2020(E)

208.3K
EPS (HKD)

2017

0.550

2018

0.640

2019

0.520

2020(E)

0.530
Price To Earnings (TTM)
9.31
Price To Sales (TTM)
0.14
Price To Book (MRQ)
0.63
Price To Cash Flow (TTM)
4.05
Total Debt To Equity (MRQ)
128.94
LT Debt To Equity (MRQ)
19.50
Return on Investment (TTM)
7.41
Return on Equity (TTM)
2.05

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up